Stocksigma LogoStocksigma Logo

Alivus Life Sciences 15th AGM Approves Dividend and Growth Strategy

Alivus Life Sciences concluded its 15th AGM on 8th Sep'26, passing all four ordinary resolutions with requisite majorities

Alivus Life Sciences 15th AGM Approves Dividend and Growth Strategy

Alivus Life Sciences Ltd 路 Annual General Meeting 路 09 Sept 2026, 1:49 am

Alivus Life Sciences 15th AGM Approves Dividend and Growth Strategy Alivus Life Sciences concluded its 15th AGM on 8th Sep'26, passing all four ordinary resolutions with requisite majorities. Key approvals include the FY26 audited financial statements, a final dividend of Rs. 5 per equity share, the reappointment of Director Hiren Patel, and the ratification of Cost Auditor remuneration for FY27. Management highlighted FY26 revenue growth, record profitability, and strong cash generation while detailing future expansion driven by an "API+" strategy and continued investments in manufacturing, R&D, and advanced pharmaceutical capabilities.

Original exchange filing (PDF)

More announcements from Alivus Life Sciences Ltd

All Alivus Life Sciences Ltd announcements